To test the extent to which secreted FNDC5 derivatives mediate GLP-1’s anti-obesity actions on adipose tissue, we treated mature 3T3-L1 adipocytes with serial concentrations of r-sFNDC5 and GLP-1. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.